http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021527071-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7064
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4365
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-06
filingDate 2019-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2021527071-A
titleOfInvention Thieno [2,3-B] pyridine derivative as an EPAC inhibitor and its pharmaceutical use
abstract The present invention is Chieno [2,3] for use in the treatment and / or prevention of diseases selected from the group consisting of inflammation, cancer, vascular disease, renal disease, cognitive impairment, pain, infectious disease, obesity and heart disease. -B] Regarding pyridine derivatives. In fact, we believe that the thieno [2,3-b] pyridine derivatives of the invention are inhibitors of the Epac protein and therefore may be useful in the prevention and / or treatment of diseases involving the Epac protein. I found. In particular, we have shown that the thieno [2,3-b] pyridine derivatives of the invention are potent, non-competitive inhibitors of Epac, and that they are downstream of Epac, such as Rap1 in cells. It was also demonstrated to inhibit the activation of effectors.
priorityDate 2018-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416134227
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1772579

Total number of triples: 23.